{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:35:25Z","timestamp":1760549725616},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"DOI":"10.2146\/ajhp140161","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T16:02:30Z","timestamp":1426694550000},"page":"525-535","source":"Crossref","is-referenced-by-count":3,"title":["Comparative efficacy and safety of insulin analogs in hospitalized adults"],"prefix":"10.1093","volume":"72","author":[{"given":"Kavita","family":"Singh","sequence":"first","affiliation":[{"name":"University of Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed T.","family":"Ansari","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, and Adjunct Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh V.","family":"Patel","sequence":"additional","affiliation":[{"name":"Adult Critical Care Medicine Training Program, University of Ottawa, and Staff Intensivist, The Ottawa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Bedard","sequence":"additional","affiliation":[{"name":"The Ottawa Hospital, Ottawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Keely","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, The Ottawa Hospital, and Professor, Departments of Medicine and Obstetrics\/Gynecology, University of Ottawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Tierney","sequence":"additional","affiliation":[{"name":"Clinical Programs, The Ottawa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Moher","sequence":"additional","affiliation":[{"name":"University of Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"suppl 1","key":"key\n\t\t\t\t2019041008215316800_b1-0720525","first-page":"S1","article-title":"Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"32","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2008","journal-title":"Can J Diabetes"},{"issue":"2","key":"key\n\t\t\t\t2019041008215316800_b2-0720525","first-page":"CD005613","article-title":"Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus","author":"Horvath","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041008215316800_b3-0720525","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00003495-200565030-00003","article-title":"A critical appraisal of the role of insulin analogues in the management of diabetes mellitus","volume":"65","author":"Oiknine","year":"2005","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2019041008215316800_b4-0720525","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1463-1326.2011.01395.x","article-title":"A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations","volume":"13","author":"Evans","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t2019041008215316800_b5-0720525","unstructured":"Formulary Search. Ontario Drug Benefit Formulary\/Comparative Drug Index. www.healthinfo.moh.gov.on.ca\/formulary (accessed 2012 Sep 21)."},{"key":"key\n\t\t\t\t2019041008215316800_b6-0720525","unstructured":"Tran K Banerjee S Li H . Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness. Technology report no. 92. www.cadth.ca\/media\/pdf\/341b_Long-acting-insulin_tr_e.pdf (accessed 2014 Dec 15)."},{"key":"key\n\t\t\t\t2019041008215316800_b7-0720525","unstructured":"Banerjee S Tran K Li H . Short-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost effectiveness (2007). Technology report no. 87. www.cadth.ca\/media\/pdf\/341A_Insulin_tr_e.pdf (accessed 2014 Dec 15)."},{"key":"key\n\t\t\t\t2019041008215316800_b8-0720525","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jclinepi.2008.10.012","article-title":"An evidence-based practice guideline for the peer review of electronic search strategies","volume":"62","author":"Sampson","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019041008215316800_b9-0720525","unstructured":"Canadian Agency for Drugs and Technologies in Health. Grey matters: a practical search tool for evidence-based medicine. www.cadth.ca\/resources\/grey-matters (accessed 2012 Dec 20)."},{"key":"key\n\t\t\t\t2019041008215316800_b10-0720525","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019041008215316800_b11-0720525","unstructured":"Higgins J Altman DG . Assessing risk of bias in included studies. www.mrc-bsu.cam.ac.uk\/cochrane\/handbook\/chapter_8\/8_assessing_risk_of_bias_in_included_studies.htm (accessed 2012 Sep 21)."},{"key":"key\n\t\t\t\t2019041008215316800_b12-0720525","unstructured":"Wells GA Shea BJ O\u2019Connell D . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (accessed 2012 Sep 24)."},{"key":"key\n\t\t\t\t2019041008215316800_b13-0720525","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041008215316800_b14-0720525","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019041008215316800_b15-0720525","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019041008215316800_b16-0720525","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019041008215316800_b17-0720525","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines: 6. Rating the quality of evidence\u2014imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019041008215316800_b18-0720525","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdiacomp.2005.06.009","article-title":"Glycemic control with regular versus lispro insulin sliding scales in hospitalized Type 2 diabetics","volume":"20","author":"Alfonso","year":"2006","journal-title":"J Diabetes Complicat"},{"key":"key\n\t\t\t\t2019041008215316800_b19-0720525","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1262-3636(07)70290-2","article-title":"Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients","volume":"32","author":"Boullu-Sanchis","year":"2006","journal-title":"Diabetes Metab"},{"key":"key\n\t\t\t\t2019041008215316800_b20-0720525","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/0253-7613.83109","article-title":"Managing diabetic ketoacidosis in non-intensive care unit setting: role of insulin analogs","volume":"43","author":"Karoli","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"key\n\t\t\t\t2019041008215316800_b21-0720525","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.clinthera.2010.10.009","article-title":"Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin","volume":"32","author":"Ko","year":"2010","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t2019041008215316800_b22-0720525","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.2337\/dc10-0957","article-title":"Glulisine versus human regular insulin in combination with glargine in noncritically ill hospitalized patients with type 2 diabetes: a randomized double-blind study","volume":"33","author":"Meyer","year":"2010","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041008215316800_b23-0720525","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.amjmed.2004.05.010","article-title":"Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis","volume":"117","author":"Umpierrez","year":"2004","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041008215316800_b24-0720525","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/diacare.27.8.1873","article-title":"Treatment of diabetic ketoacidosis with subcutaneous insulin aspart","volume":"27","author":"Umpierrez","year":"2004","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041008215316800_b25-0720525","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/dc09-0169","article-title":"Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial","volume":"32","author":"Umpierrez","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041008215316800_b26-0720525","first-page":"1064","article-title":"Evaluation of the cost-effectiveness of different insulin regimes during the peri-operative period in type-2 diabetics in India","volume":"5","author":"Ahmad","year":"2011","journal-title":"J Clin Diagn Res"},{"key":"key\n\t\t\t\t2019041008215316800_b27-0720525","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4158\/EP10358.OR","article-title":"Insulin injections in relation to meals in the hospital medicine ward: comparison of 2 protocols","volume":"17","author":"Guerra","year":"2011","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041008215316800_b28-0720525","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0884533611420727","article-title":"Comparison of 70\/30 biphasic insulin with glargine\/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy","volume":"26","author":"Hsia","year":"2011","journal-title":"Nutr Clin Pract"},{"key":"key\n\t\t\t\t2019041008215316800_b29-0720525","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/jc.2008-1441","article-title":"Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine Hagedorn plus regular in medical patients with type 2 diabetes","volume":"94","author":"Umpierrez","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041008215316800_b30-0720525","first-page":"759","article-title":"Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens","volume":"107","author":"Mathur","year":"2009","journal-title":"J Indian Med Assoc"},{"key":"key\n\t\t\t\t2019041008215316800_b31-0720525","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/dia.2011.0157","article-title":"Glucose control in acute myocardial infarction: a pilot randomized study controlled by continuous glucose monitoring system comparing the use of insulin glargine with standard of care","volume":"14","author":"Sampaio","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"key\n\t\t\t\t2019041008215316800_b32-0720525","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/dia.2006.8.609","article-title":"Comparison of once-daily glargine insulin with twice-daily NPH\/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery","volume":"8","author":"Yeldandi","year":"2006","journal-title":"Diabetes Technol Ther"},{"key":"key\n\t\t\t\t2019041008215316800_b33-0720525","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/0884533609351531","article-title":"Evaluation of glycemic control using NPH insulin sliding scale versus insulin aspart sliding scale in continuously tube-fed patients","volume":"24","author":"Cook","year":"2009","journal-title":"Nutr Clin Pract"},{"key":"key\n\t\t\t\t2019041008215316800_b34-0720525","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4158\/EP.13.3.225","article-title":"Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial","volume":"13","author":"Datta","year":"2007","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041008215316800_b35-0720525","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14017430701721756","article-title":"Insulin glargine improves glycaemic control after coronary surgery in patients with diabetes or pre-diabetes","volume":"42","author":"Hagelberg","year":"2008","journal-title":"Scand Cardiovasc J"},{"key":"key\n\t\t\t\t2019041008215316800_b36-0720525","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5694\/mja11.10853","article-title":"Basal-bolus insulin versus sliding-scale insulin for inpatient glycaemic control: a clinical practice comparison","volume":"196","author":"Roberts","year":"2012","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t2019041008215316800_b37-0720525","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/dc07-0295","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial)","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041008215316800_b38-0720525","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041008215316800_b39-0720525","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4158\/EP.14.2.185","article-title":"Inpatient glycemic control on the vascular surgery service","volume":"14","author":"Theilen","year":"2008","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041008215316800_b40-0720525","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.athoracsur.2010.07.063","article-title":"Effects of moderate intensity glycemic control after cardiac surgery","volume":"90","author":"Leibowitz","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t2019041008215316800_b41-0720525","unstructured":"Institute for Quality and Efficiency in Health Care. Long-acting insulin analogues in the treatment of diabetes mellitus type 2 (2005). IQWiG report no. A05-03. www.iqwig.de\/index.media.538df941a1d274bea0b8b1f9ae06921b.pdf (accessed 2014 Dec 15)."},{"key":"key\n\t\t\t\t2019041008215316800_b42-0720525","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1503\/cmaj.081041","article-title":"Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis","volume":"180","author":"Singh","year":"2009","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t2019041008215316800_b43-0720525","unstructured":"Institute for Quality and Efficiency in Health Care. Rapid-acting insulin analogues in the treatment of diabetes mellitus type 1 (2007). IQWiG report no. A05-02. www.iqwig.de\/en\/projects-results\/projects\/drug-assessment\/a05-02-rapid-acting-insulin-analogues-in-the-treatment-of-diabetes-mellitus-type-1.1195.html (accessed 2014 Dec 15)."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/7\/525\/28319179\/ajhp0525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T03:32:47Z","timestamp":1566444767000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/7\/525\/5111493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140161","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,4,1]]},"published":{"date-parts":[[2015,4,1]]}}}